Liberg; David
Patent Applications and Registrations
Patent applications and USPTO patent grants for Liberg; David.The latest application filed is for "anti-il1rap antibody compositions".
- Liberg; David - Lomma SE
- Liberg; David - Vintrie SE
| Patent | Date |
|---|---|
| Anti-IL1RAP Antibody Compositions App 20220267454 - Forsberg; Goran ; et al. | 2022-08-25 |
| Anti-IL1RAP antibody App 20220242950 - Liberg; David ; et al. | 2022-08-04 |
| Quinoline carboxamides for use in the treatment of multiple myeloma Grant 10,314,836 - Liberg , et al. | 2019-06-11 |
| N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitors Grant 10,125,125 - Fritzson , et al. November 13, 2 | 2018-11-13 |
| Quinoline Carboxamides For Use In The Treatment Of Multiple Myeloma App 20180228794 - LIBERG; David ; et al. | 2018-08-16 |
| N-(heteroaryl)-sulfonamide Derivatives Useful As S100-inhibitors App 20180155330 - FRITZSON; Ingela ; et al. | 2018-06-07 |
| Quinoline carboxamides for use in the treatment of multiple myeloma Grant 9,956,212 - Liberg , et al. May 1, 2 | 2018-05-01 |
| N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitors Grant 9,873,687 - Fritzson , et al. January 23, 2 | 2018-01-23 |
| Quinoline Carboxamides For Use In The Treatment Of Multiple Myeloma App 20170273967 - LIBERG; David ; et al. | 2017-09-28 |
| Compounds useful as S100-inhibitors Grant 9,771,372 - Wellmar , et al. September 26, 2 | 2017-09-26 |
| Novel Compounds Useful As S100-inhibitors App 20170204098 - WELLMAR; Ulf ; et al. | 2017-07-20 |
| N-(heteroaryl)-sulfonamide Derivatives Useful As S100-inhibitors App 20160115158 - FRITZSON; Ingela ; et al. | 2016-04-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 